| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |